David Warr

9.3k citations

103 papers · 6.4k indexed · 2 hit papers · h-index 41

Impact in

Anesthesiology and Pain Medicine top 0.5%
Internal Medicine top 1%

Papers in ⓘ

Surgery 63
- Nausea and vomiting management 59
- Anesthesia and Pain Management 36
Oncology 36
- Cancer survivorship and care 17
- Cancer Treatment and Pharmacology 14

Co-authors: Paul J. Hesketh (18 shared papers)Joseph L. Pater (12 shared papers)Jean Latreille (12 shared papers)Benny Zee (9 shared papers)David Osoba (9 shared papers)Richard J. Gralla (16 shared papers)Fausto Roila (16 shared papers)Alexandra D. Carides (7 shared papers)
Journals: Supportive Care in Cancer (29 papers)Journal of Clinical Oncology (20 papers)Annals of Oncology (5 papers)Journal of Pain (5 papers)Breast Cancer Research and Treatment (5 papers)
Partner nations: Canada United States Italy

In The Last Decade

David Warr

100 papers receiving 6.2k citations

Hit Papers

align trajectories log scale

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients 2016 · 397 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Annals of Oncology
2003 Journal of Clinical Oncology

Peers

Countries citing papers authored by David Warr

Since Specialization

Citations

This map shows the geographic impact of David Warr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Warr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Warr more than expected).

Fields of papers citing papers by David Warr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Warr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Warr. The network helps show where David Warr may publish in the future.

Co-authors

The 25 scholars most cited alongside David Warr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Warr Line = papers co-authored together David Warr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group Journal of Clinical Oncology ·Paul J. Hesketh, Steven M. Grunberg, Richard J. Gralla, David Warr, Fausto Roila, Ronald de Wit, Sant P. Chawla, Alexandra D. Carides, Juliana Ianus, M. Elmer, Judith K. Evans, Klaus Beck, Scott A. Reines, Kevin Horgan Hit paper breakdown →	2003	593
2	Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology ·Mark N. Levine, V. Bramwell, Kathleen I. Pritchard, B. Norris, Lois E. Shepherd, Hakam Abu-Zahra, B. Findlay, David Warr, David M. J. S. Bowman, James D. Myles, Andrew Arnold, Ted Vandenberg, Robert G. MacKenzie, J Robert, J. Ottaway, Margot J. Burnell, Christopher Kwesi O. Williams, Dan‐Na Tu	1998	442
3	Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer The Lancet ·(unknown), Mark N. Levine, J. Hirsh, (unknown), Michael Gent, (unknown), (unknown), V. Bramwell, Kathleen I. Pritchard, David W. Stewart, David Warr, Pamela J. Goodwin, Martin Samosh, Anna Falanga	1994	400
4	2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients Annals of Oncology ·Fausto Roila, Alex Molassiotis, Jørn Herrstedt, Matti Aapro, Richard J. Gralla, Éduardo Bruera, Rebecca Clark-Snow, L. Lee Dupuis, Lawrence H. Einhorn, Petra Feyer, Paul J. Hesketh, Karin Jordan, Ian Olver, Bernardo L. Rapoport, Joseph A. Roscoe, Christina H. Ruhlmann, Declan Walsh, David Warr, M. van der Wetering Hit paper breakdown →	2016	397
5	Efficacy and Tolerability of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer After Moderately Emetogenic Chemotherapy Journal of Clinical Oncology ·David Warr, Paul J. Hesketh, Richard J. Gralla, Hyman B. Muss, Jørn Herrstedt, Peter D. Eisenberg, Harry Raftopoulos, Steven M. Grunberg, Munir Gabriel, Anthony Rodgers, Norman R. Bohidar, George Klinger, Carolyn M. Hustad, Kevin Horgan, Franck Skobieranda	2005	370
6	Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer Quality of Life Research ·David Osoba, Benny Zee, Joseph L. Pater, David Warr, L Kaizer, Jean Latreille	1994	347
7	Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer Journal of Clinical Oncology ·Nadine Tchen, Helen G. Juffs, Fiona Downie, Qilong Yi, Hanxian Hu, I. Chemerynsky, Mark Clemons, Michael Crump, Paul E. Goss, David Warr, M. Tweedale, Ian F. Tannock	2003	290
8	A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer Psycho-Oncology ·A. J. Cunningham, Claire V.I. Edmonds, Gwen Jenkins, Herbert B. Pollack, Gina Lockwood, David Warr	1998	195
9	Effect of postchemotherapy nausea and vomiting on health-related quality of life Supportive Care in Cancer ·David Osoba, Benny Zee, David Warr, Jean Latreille, Leonard Kaizer, Joseph L. Pater	1997	170
10	Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology ·David Osoba, Benny Zee, Joseph L. Pater, David Warr, Jean Latreille, L Kaizer	1997	163
11	Small-cell carcinoma of the lung: derivation of a prognostic staging system. Journal of Clinical Oncology ·Uri Sagman, Ellen Maki, William K. Evans, David Warr, Frances A. Shepherd, Jean‐Paul Sculier, Riad Haddad, David G. Payne, J. F. Pringle, J L Yeoh	1991	119
12	Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response. Journal of Clinical Oncology ·David Warr, Steven McKinney, Ian F. Tannock	1984	110
13	Aprepitant and Fosaprepitant: A 10-Year Review of Efficacy and Safety The Oncologist ·Matti Aapro, Alexandra D. Carides, Bernardo L. Rapoport, Hans‐Joachim Schmoll, Li Zhang, David Warr	2015	101
14	The oral NK1 antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials European Journal of Cancer ·David Warr, Steven M. Grunberg, Richard J. Gralla, Paul J. Hesketh, Fausto Roila, Ronald de Wit, Alexandra D. Carides, Arlene Taylor, Judith K. Evans, Kevin Horgan	2005	100
15	2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk Chemotherapy Supportive Care in Cancer ·Jørn Herrstedt, Fausto Roila, David Warr, Luigi Celio, Rudolph M. Navari, Paul J. Hesketh, Alexandre Chan, Matti Aapro	2016	98
16	Efficacy and tolerability of aprepitant for the prevention of chemotherapy‐induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy Cancer ·Jørn Herrstedt, Hyman B. Muss, David Warr, Paul J. Hesketh, Peter D. Eisenberg, Harry Raftopoulos, Steven M. Grunberg, Munir Gabriel, Anthony Rodgers, Carolyn M. Hustad, Kevin Horgan, Franck Skobieranda, (unknown)	2005	96
17	Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology ·Jean Latreille, Joseph L. Pater, D. Johnston, Francis Laberge, Douglas Stewart, James J. Rusthoven, Paul Hoskins, Briar Findlay, E.J. McMurtrie, Louise Yelle, Christopher Kwesi O. Williams, David Walde, S. Ernst, Harpal S. Dhaliwal, David Warr, Frances A. Shepherd, D. Le Mée, Lyn Y. Nishimura, David Osoba, Benny Zee	1998	93
18	Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology ·L Kaizer, David Warr, Paul Hoskins, Jean Latreille, W. Lofters, J. Yau, Michael Palmer, Benny Zee, Maurice Levy, Joseph L. Pater	1994	92
19	Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin–cyclophosphamide-based chemotherapy Supportive Care in Cancer ·David Warr, James C. Street, Alexandra D. Carides	2010	91
20	Multicenter, Randomized, Cross-Over Clinical Trial of Venlafaxine Versus Gabapentin for the Management of Hot Flashes in Breast Cancer Survivors Journal of Clinical Oncology ·Louise Bordeleau, Kathleen I. Pritchard, Charles L. Loprinzi, Marguerite Ennis, O. Jugovic, David Warr, Rashida Haq, Pamela J. Goodwin	2010	86

About David Warr

David Warr is a scholar working on Surgery, Oncology, Physiology, Anesthesiology and Pain Medicine and Pediatrics, Perinatology and Child Health, having authored 103 papers that have together received 6.4k indexed citations. Recurring topics across this work include Nausea and vomiting management (59 papers), Anesthesia and Pain Management (36 papers), Pathogenesis and Treatment of Hiccups (21 papers), Cancer survivorship and care (17 papers), Cancer Treatment and Pharmacology (14 papers), Pain Management and Opioid Use (12 papers), Breast Cancer Treatment Studies (7 papers) and Sympathectomy and Hyperhidrosis Treatments (7 papers). The work is most often cited by research in Anesthesiology and Pain Medicine (512 citations), Internal Medicine (329 citations), Oncology (2.0k citations), Surgery (3.2k citations) and Physiology (1.6k citations). David Warr has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Paul J. Hesketh, Joseph L. Pater, Jean Latreille, Benny Zee, David Osoba, Richard J. Gralla, Fausto Roila, Alexandra D. Carides, Steven M. Grunberg and L Kaizer. Their work appears in journals such as Supportive Care in Cancer, Journal of Clinical Oncology, Annals of Oncology, Journal of Pain and Breast Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact